Into 2019: Regulatory Pressures Of The EU's Medical Device Regulation Will Spread Into Asia
The extra resources, time and expense that the EU Medical Device Regulation (MDR) will mean for companies in Europe has been a dominant theme since spring 2017, but the repercussions on non-European markets that rely on EU medtech legislation – in Asia, for example – are now coming to the fore, says regional medtech regulatory specialist Jack Wong.
You may also be interested in...
The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.
Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available. A new “future hospitals investment” program, now made into a draft law, should reserve funds for robotics and digital health care.
In this Device Week, Ashley Yeo asks PB Consulting managing director Dan Jones about the adjustments needed by UK medtechs as they face a confluence of change brought about by Brexit, COVID-19 and NHS reform, at a time when the MHRA is also coming under increased scrutiny.